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Abstract Background Turner syndrome (TS) is associated with aortic dilatation and dissection,
but the underlying process is unclear. The aim of this study was to investigate the
elastic properties and composition of the aortic wall in women with TS.
Methods In this cross-sectional study, 52 women with TS aged 35 13 years (50%
monosomy, 12 with bicuspid aortic valve [BAV] and 4 with coarctation) were
investigated using carotid-femoral pulse wave velocity (CF-PWV) by echocardiography
and ascending aortic distensibility (AAD) and aortic arch pulse wave velocity (AA-PWV)
by magnetic resonance imaging (MRI). As control group, 13 women with BAV without
TS and 48 healthy patients were included.
Results Women with TS showed a higher AA-PWV (β¼ 1.08, confidence interval [CI]:
0.54–1.62) after correcting for age and comorbidities compared with controls. We
found no significant difference in AAD and CF-PWV. In women with TS, the presence of
BAV, coarctation of the aorta, or monosomy (45, X) was not associated with aortic
stiffness. In addition, aortic tissue samples were investigated with routine and
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Introduction
Turner syndrome (TS) is a genetic condition caused by partial
or complete absence of an X chromosome and occurs in 50
per 100,000 females at birth.1 The main complication is
aortic dissection, most often preceded by aortic dilatation,2
which carries a substantial mortality risk.3 To prevent acute
aortic dissection, preventive surgery is advised when the
aortic diameter exceeds a diagnosis-specific cut-off value.
Since patients with TS are known for their short stature,
correction for body size area using the aortic size index is
advised.4 However, even patients with a normal aortic size
index may develop aortic dissection.5 Consequently, aortic
dilatation alone is not sufficient for identifying patients with
TS at high risk of aortic dissection. Other clinical parameters
identifying high-risk patients are not very clear.6
It has been proposed that other more subtle changes such
as increased stiffness of the aortic wall, are present in
patients with TS prior to dissection. Studies in patients
with hypertension, diabetes, or ischemic heart disease
have shown aortic stiffness to be an independent predictor
of all-cause mortality and cardiovascular events.7 Although
previous literature showed an increased aortic stiffness in
patients with TS,8–10 it remains unclear towhat extent this is
explained by the commonly found bicuspid aortic valve
(BAV) and coarctation of the aorta (CoA). Both BAV and
CoA are also associated with aortic stiffness,11,12 and it is
known that dissection may occur in the absence of BAV and
CoA.13 Differences in aortic stiffness between monosomy
(45, X) and mosaicism have also not yet been investigated.
In addition, histomorphological examination of aortic
tissue frompatients might also be of help to identify possible
pathological changes in the aortic wall and to interpret aortic
stiffness imaging parameters.
The aim of this current study was to investigate whether
the aortic wall of patients with TS is different from that of
healthy control patients, and if this can be explained solely
by the bicuspid valve and/or aortic coarctation.
Materials and Methods
In this cross-sectional cohort study, we included all adult
patients with TS who participated between October 2014
and March 2016 in a study previously described.14 Inclusion
criteria for patients with TS were a 45, X or 45, X/46, and XX
mosaic karyotype. The patients were prospectively included
and subjected to physical examination (including height,
weight, and systolic and diastolic blood pressure), electrocar-
diography, two- and three-dimensional (2D and 3D, respec-
tively) echocardiography, computed tomography angiography
(CTA), and magnetic resonance imaging (MRI), all on the
same day.
Measurements of the aortic diameter were performed
using the double-oblique technique on CTA during systole,
except for two patients. In those two patients, contrast-
enhancedmagnetic resonance angiography (CEMRA) images
were used, as CTAwas not performed. Scan parameters of the
CT imaging can be found elsewhere.14
Two reference groups were selected: patients with BAV
without TS and healthy control women.We selected patients
with BAV from the same prospective cohort study from
which the patients with TS were included. The inclusion
criteria for BAV were age 18 years and one of the following
features: (1) aortic stenosis (gradient >2.5 m/sec), (2) aortic
regurgitation (at least moderate), or (3) ascending aortic
diameter 40mm and/or aortic size index >2.1.
For carotid-femoral pulse wave velocity (CF-PWV) meas-
urements, we included a statistically age-matched control
group. They did not undergo CTA or MRI and therefore aortic
diameters were measured during midsystole with echocar-
diography in this group of healthy patients using the leading-
edge-to-leading-edge technique.
The healthy control group for aortic distensibility and
aortic arch pulse wave velocity (AA-PWV) measurements
were recruited from a previous MRI study on aortic stiffness
of patients with the same age.15
The studywas approved by themedical ethical committee
(MEC14–225).Written informed consent was provided by all
patients and controls.
A standard 2D transthoracic echocardiogram was per-
formed by an experienced sonographer. All studies were
acquired using harmonic imaging on an iE33 or EPIQ7 ultra-
sound system (PhilipsMedical Systems, Best, theNetherlands)
equippedwith an x5–1matrix-array transducer (composed of
3040 elements operating at 1–5MHz). The aorta was mea-
sured in the standard parasternal long axis view or on a more
cranial view one intercostal space higher which often im-
proved the visualization of the ascending aorta.
PW Doppler signals were obtained consecutively at
the common carotid artery and the femoral artery
(►Supplementary Fig. S1, panel A). PWV (expressed in
m/s) was defined as: distance (in meters) between carotid
artery and femoral artery/delta time (in seconds). The dis-
tance was measured outside the patient’s body with a
measuring tape. For both signals, the time interval was
measured between the onset of the QRS complex and the
onset of the systolic PW Doppler signal. Delta time was
The tissue showed more compact smooth muscle cell layers with abnormal deposition
and structure of elastin and diminished or absent expression of contractile proteins
desmin, actin, and caldesmon, as well as the progesterone receptor.
Conclusion Both aortic arch stiffness measurements on MRI and histomorphological
changes point toward an inherent abnormal thoracic aortic wall in women with TS.
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calculated as the difference between both time intervals.
Validated software was used to analyze the PWV (Curad
Viewer version 3.5.3.0, Wijk bij Duurstede, the Netherlands).
Image acquisition was performed using a 1.5-T scanner
(Discovery MR450, GE Medical Systems, Milwaukee, WI, USA)
using a 32-channel phased-array cardiac surface coil. A retro-
spectively echocardiography (ECG)-gated 2D balanced steady-
state freeprecessionsequenceduringbreathholdwasobtained
perpendicular to the ascending aorta at the level of the
pulmonary trunk to measure aortic distensibility. Typical
scan parameters were as follows: field of view (FOV) 420mm
(phase FOV 60%); matrix size, 256 192; slice thickness,
6.5mm; flip angle, 45 degrees; repetition time/echo time
(TR/TE), 3.3/1.5ms; and number of reconstructed phases, 24
per cardiac cycle. The contour of the ascending aorta was
manually traced in all phases (QMass analytical software
version 8.1, Medis, Leiden, the Netherlands). The minimum
and maximum ascending aortic cross-sectional areas were
identified, and aortic distensibility (10–3mm Hg1) was cal-
culated using the following calculation: (maximum area –
minimum area)/(minimum area ΔP) 1,000, where ΔP is
the brachial pulse pressure in mmHg (►Supplementary
Fig. S1, panel B).
A free-breathing, retrospectively ECG-gated 2D phase-con-
trastflowsequencewasperformed tomeasure aortic PWV. The
slice planewas positioned at the level of the pulmonary artery
perpendicular to the ascending and descending aorta. Typical
scan parameters were as follows: FOV, 350mm (phase FOV
90%);matrix size, 192 160; slice thickness, 7.0mm;flipangle,
20 degrees;number ofaverages, 3; TR/TE, 4.3/2.3ms; viewsper
segment, 1; velocity encoding value, 200 cm/s; true temporal
resolution, approximately 11ms; andnumber of reconstructed
phases, 100 per cardiac cycle. AA-PWVwas defined as distance
between ascending and descending aorta/Δ time (expressed in
m/s). Delta time was measured with the same method
explained by Devos et al9 (►Supplementary Fig. S1, panel
C). Theonsetof thesystolicwavefrontwasdeterminedfromthe
resulting flow graph by the intersection point of the constant
horizontal diastolic flow and the upslope of the systolic wave
front, the latter of which was modeled by linear regression
along the upslope from theflow values between 20 and 80% of
the total range. To determine the length of the aortic segment
between the two aortic levels, sagittal angulated T1-weighted
black blood turbo spin echo images of the AA were acquired
during breath-hold. Typical scan parameters were FOV,
400mm (phase FOV 100%); matrix, 256 256; slice thickness,
5.0mm; and flip angle, 155 degrees. When the AA was not
properly visible on the black blood images a multiplanar
reconstruction was made with CEMRA images to measure
the distance (n¼ 35, 47%). The CEMRA scan parameters are
described elsewhere.14 Qmass software was used for disten-
sibility measurements and Qflow software was used for PWV
measurements (Medis, Leiden, the Netherlands).
We studied the histomorphology of formalin-fixed paraf-
fin-embedded (FFPE) specimens of the ascending aorta of
five TS patients who underwent preventive replacement of
the ascending aorta because of dilatation. In one patient, we
additionally performed electron microscopy examination to
ultrastructurally investigate medial elastin fiber morphology
and deposition of elastin. To clearly show the differences
between aortic tissue of patients with TS and healthy tissue,
aortic tissue from a healthy woman aged 45 years was
obtained from the Heart Valve Bank in Rotterdam and
investigated.
Routine staining with hematoxylin–eosin (HE), the elastica
vanGieson (EvG), andalcianblue (AB) stainswasperformedon
3 μm sections. The criteria as outlined in the recent consensus
statement on surgical pathology of the aorta16 were used for
scoring and classification of abnormalities. In addition, immu-
nohistochemical stains were performed on a Ventana Bench-
mark Ultra-automated staining platform (Roche Diagnostics,
Tucson, AZ) to assess the vessel wall expression of smooth
muscle actin (SMA), caldesmon, desmin, actin HHF-35, estro-
gen receptor (ER), and progesterone receptor (PR), as well as
the proliferation marker MIB-1. Immunohistochemical meth-
ods including the antibody clones used are provided in the
Supplementary Material (►Supplementary Appendix A). For
electron microscopy, representative samples of the media
were isolated from paraffin blocks and incubated with a
mixture of 1% glutaraldehyde and 4% formaldehyde. The
sections were osmicated with 1% osmium in distilled water,
dehydrated in 50 to 100% Acetone and embedded in amixture
of Embed-812, NMA, DDSA, and DMP-30 (EMS diasum, Hat-
field, Pennsylvania). Ultrathin sections (60–70 nm) were cut
using an Ultramicrotome UC7 (Leica, Germany), mounted on
copper grids, and counterstained with uranyl acetate 0,5% for
30minutes at 45°C and Ultrostain II (Leica, Germany) for
7minutes at room temperature in the Leica AC20. Elastin
lamellae were visualized at magnifications of 2,800 and
7,100 and analyzed under the electron microscope (Philips,
Eindhoven, the Netherlands).
All characteristics are presented as mean standard de-
viationwhen normally distributed, and in case of nonnormal
distribution, medians (interquartile ranges [IQR]) are pro-
vided. Categorical variables are presented as frequencies
with percentages. Comparison of normally distributed con-
tinuous variables between two groups was done using the
Student’s t-test or, in case of a skewed distribution, the
Mann–Whitney test. Univariable linear regression analysis
was performed with patient characteristics as independent
variables and the measurement of aortic stiffness as depen-
dent variable. In addition, multivariable analysis was per-
formed using the Enter method to adjust for age, aortic size
index, BAV, CoA, and hypertension. To assess interobserver
variability, the intraclass correlation coefficient (ICC) was
calculated for all measurements using 25 randomly selected
patients. The IBM SPSS statistics 21.0 software was used to
analyze the data. The statistical tests were two sided and a p-
value below 0.05 was considered significant.
Results
In total, 52womenwith TS aged 35 14 yearswere included:
40 with a tricuspid aortic valve (TAV) and 12 patients with
BAV. Twenty-five TS women had X chromosome monosomy
(45, X) and the other 25 TS women had X chromosome
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mosaicism (n¼ 2 missing). Renal function was normal in all.
In 13 women (25%), the time between the first and last
investigation was 1 day (median, 7 days; IQR: 5–42 days)
due to technical or practical issues. We included 13 women
with BAV without TS and 10 healthy women for the control
groups of CF-PWV. The control group for aortic distensibility
and AA-PWVmeasurements consisted of the same 13 wom-
en with BAV and an additional 38 healthy female patients.
In ►Fig. 1, a flowchart is presented with the number of
measurements that could be performed in the participants.
►Table 1 shows the baseline patient characteristics of the TS
women and control groups separately. Surgical correction for
CoA with end-to-end anastomosis was performed in three
patients with TS. Five patients with TS were treated for
hypertensionwith β-blockers, angiotensin receptor blockers,
or angiotensin converting enzyme (ACE) inhibitors.
►Figure 2 shows the comparison between patients with
TS and controls for the CF-PWV, ascending aortic distensibil-
ity and AA-PWV. We found no significant difference in CF-
PWV between the groups. Within the women with TS,
Fig. 1 Flow chart of the patients with aortic stiffness measurements. All three measurements could be performed in 32 patients with Turner
syndrome (25 TAV and 7 BAV) and in 8 control patients with BAV only. BAV, bicuspid aortic valve; PWV, pulse wave velocity; TAV, tricuspid aortic
valve.
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Table 1 Baseline characteristics















Age (y) 35 14 36 14 35 13 34 11 35 15 34 14
Height (cm) 156 9 157 9 154 7 169 11 187 6 166 8
Weight (kg) 66 16 68 17 61 11 69 11 83 10 61 11
Systolic blood
pressure (mm Hg)
124 17 124 18 126 16 116 12 131 10 118 14
Diastolic blood
pressure (mm Hg)
80 13 80 12 83 14 77 7 79 7 70 9
Hypertension 8 (15%) 7 (18%) 1 (8%) 3 (23%) 0 (0%) 0 (0%)
Surgical correction
for aortic coarctationa




11 (21%) 6 (15%) 5 (42%) 9 (69%) 0 (0%) 1 (3%)b
Aortic stenosis
(echo Vmax >2.5 m/s)
1 (2%) 0 (0%) 1 (8%) 11 (85%) 0 (0%) 0 (0%)
Aortic regurgitation
(moderate or severe)
1 (2%) 0 (0%) 1 (8%) 5 (39%) 0 (0%) 0 (0%)
Absolute ascending
aortic diameter (mm)
31 5 30 4 33 6 40 7 31 3 27 3
Aortic size index
ascending aorta (mm/m2)
19 4 18 3 21 3 22 3 15 2 16 2
ASI, aortic size index (aortic diameter divided by body surface area); BAV, bicuspid aortic valve; MRI, magnetic resonance imaging; TAV, tricuspid
aortic valve; Vmax, maximum velocity.
Note: data are expressed as mean standard deviation or n (percentage).
Missing values were present for height (n¼ 1) and weight (n¼ 1), blood pressure (n¼ 6) and aortic size index (n¼ 1).
aOne additional Turner patient has a coarctation of the aorta, but he did not undergo surgical correction.
bOne healthy woman with an aortic diameter of 29 mm, height of 151 cm and weight of 40 kg, which resulted in an ASI of 2.2 cm/m2.
Fig. 2 Uncorrected results of carotid-femoral pulse wave velocity, ascending aortic distensibility, and aortic arch pulse wave velocity divided
into four groups. The median level in each subgroup is indicated with the black line. BAV, bicuspid aortic valve; PWV, pulse wave velocity; TAV,
tricuspid aortic valve.  Significantly different from the healthy group according to the Wilcoxon’s one-sample test.
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patients with BAV (median¼ 7.0, IQR: 6.1–7.7 m/s) did not
show a significantly different CF-PWV compared with the
patients without BAV (median¼ 6.7, IQR: 5.8–8.5 m/s). In all
four TS women with CoA, the CF-PWV could be measured
(5.3, 6.9, 7.6, and 7.8 m/s) and was not statistically different
from TS women without CoA (median¼ 6.7, IQR: 5.9–8.4
m/s). Also, no statistical difference was found between
patients with monosomy (median¼ 6.5, IQR: 5.7–7.7 m/s)
or mosaicism (median¼ 6.9, IQR: 6.4–8.6 m/s). For CF-PWV
measurements we found an ICC of 0.893 (0.772–0.951).
We found no significant difference in ascending aortic
distensibility between the groups. Within the women with
TS, patients with BAV (median¼ 5.7, IQR: 2.5–8.3mm Hg1)
did not show a significantly different ascending aortic disten-
sibilitycomparedwiththepatientswithoutBAV(median¼ 5.3,
IQR: 2.6–7.6mm Hg1). Only in two TS women with CoA, the
ascending aortic distensibility could be measured (1.5 and
6.2 103 mm Hg1). No statistical difference was found
between patients with monosomy (median¼ 5.2, IQR:
3.9–7.1mm Hg1) or mosaicism (median¼ 5.6, IQR:
2.3–8.3mmHg1). Forascendingaorticdistensibilitymeasure-
mentswefoundanICCof0.999 (0.996–0.999) for theminimum
area and 0.999 (0.998–1.000) for the maximum area.
Patients with TS showed significantly higher AA-PWV
compared with healthy controls (►Fig. 2). In the multivari-
able analysis (►Table 2), the presence of TS remained signif-
icantly associated with higher AA-PWV (β¼ 1.08, 95%
confidence interval [CI]: 0.54–1.62, p< 0.001). Within the
patients with TS, patients with BAV (median¼ 4.8, IQR:
4.4–6.0 m/s) did not show a significantly different AA-
PWV compared with the patients without BAV (medi-
an¼ 5.3, IQR: 4.5–6.1 m/s). In three TS women with CoA,
the AA-PWVcould bemeasured (4.4, 5.8, and 6.4m/s), which
was comparable to the median of TS women without CoA
(median¼ 4.9, IQR: 4.5–5.9 m/s). No statistical difference
was found between patients with monosomy (median¼ 4.7,
IQR: 4.4–5.8 m/s) or mosaicism (median¼ 5.5, IQR: 4.5–6.2
m/s). For AA-PWV measurements, we found an ICC of 0.970
(0.935–0.987) for the distance measurements and 0.704
(0.437–0.857) for the time measurements.
The five patients with TS who underwent surgery had an
age range of 11 to 47 years at time of surgery.
►Supplementary Table S1 shows a complete overview of
the routine stains of each patient. Using the criteria outlined
in the recent consensus statement, the patients were found
to show only mild medial degeneration in four patients, and
no medial degeneration in one patient, with mostly intra-
lamellar and focal, mucoid matrix accumulation (►Fig. 3). In
addition to thesefindings, we found compact smoothmuscle
cell layers and a decrease in the intralamellar space, but only
mild smooth muscle cell nuclei loss. Also, conspicuous
granular deposition of elastin adjacent to lamellaewas found
Table 2 Univariable and multivariable analysis of aortic stiffness measurements in the total group including patients with Turner
syndrome, bicuspid aortic valve patients and control patients
Characteristics Univariable analysis Multivariable analysisa
Beta (95% CI) p-Value Beta (95% CI) p-Value
Carotid-femoral
PWV (n¼ 69)
Turner Syndrome 0.54 (0.34; 1.42) 0.223 0.03 (0.65; 0.72) 0.924
Age 0.09 (0.06; 0.11) <0.001 0.06 (0.04; 0.09) <0.001
Baseline aortic size index 0.16 (0.05; 0.27) 0.004 0.14 (0.04; 0.25) 0.007
Bicuspid aortic valve 0.67 (1.54; 0.21) 0.132 1.03 (1.95; 0.12) 0.028
Aortic coarctation 0.42 (2.01; 1.16) 0.596 0.53 (0.76; 1.82) 0.413




Turner Syndrome 1.01 (2.5; 0.51) 0.191 0.87 (1.99; 0.25) 0.126
Age 0.18 (0.22; 0.14) <0.001 0.18 (0.23; 0.14) <0.001
Baseline aortic sixe index 0.15 (0.36; 0.07) 0.181 0.11 (0.11; 0.32) 0.327
Bicuspid aortic valve 0.09 (1.97; 1.79) 0.926 0.33 (2.17; 1.52) 0.726
Aortic coarctation 1.38 (5.00; 2.24) 0.451 1.86 (4.79; 1.07) 0.210
Hypertension 3.61 (6.13; 1.09) 0.005 1.25 (3.35; 0.85) 0.238
Aortic arch
PWV (n¼ 87b)
Turner Syndrome 1.34 (0.72; 1.95) <0.001 1.08 (0.54; 1.62) <0.001
Age 0.06 (0.04; 0.08) <0.001 0.05 (0.03; 0.07) <0.001
Baseline aortic sixe index 0.14 (0.05; 0.24) 0.004 0.06 (0.03; 0.16) 0.198
Bicuspid aortic valve 0.18 (0.62; 0.99) 0.651 0.35 (1.17; 0.47) 0.395
Aortic coarctation 1.39 (0.27; 2.50) 0.015 0.66 (0.35; 1.67) 0.195
Hypertension 2.47 (1.42; 3.52) <0.001 0.80 (0.24; 1.85) 0.131
Abbreviations: PWV, pulse wave velocity.
Note: bold¼ statistical significant in multivariabele analysis.
aCorrected for all other variables mentioned in this table.
bOne patient had a missing value for weight.
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in aortic tissue of women with TS when compared with
healthy controls (►Fig. 3). Additional electron microscopic
images confirmed these granular structures by showing
“bulges” on the surface of elastin fibers (►Fig. 4). The elastin
fibers themselves were positioned closer together and were
more irregular and thinner comparedwith a healthy control.
Immunohistochemically, the most striking findings were
seen in the middle section of the media with a complete
lack of desmin expression in all five patients, underexpres-
sion of caldesmon and progesterone receptor in four out of
five, and weak expression of HHF-35 in three out of five
patients (►Fig. 5). We observed apparent overexpression of
estrogen receptor in themedia of TS patients, while SMA and
MIB-1 were not differentially expressed.
Discussion
The results of our study show that women with TS have a
stiffer AA compared with controls, independent of the
presence of BAV or CoA. Ascending aortic distensibility and
CF-PWV were not statistically different between patients
with TS and controls.We also found no effect of karyotype on
Fig. 3 Routine stains of aortic tissue of patients with Turner syndrome and healthy controls. Top row: (A) hematoxylin–eosin, (B) Elastica-van
Gieson, and (C) alcian blue stains of a representative aortic explant of a Turner syndrome patient, with essentially intact lamellation, and only
minimal elastin fragmentation (B) and mucin deposition (C, arrow). Second row: (D) control case lacking significant degeneration in
hematoxylin–eosin stains, (E) Elastica-van Gieson stains, or (F) alcian blue stains. Third row: (G) Turner case lacking significant degeneration in
hematoxylin-eosin stains or (H, I) Elastica-van Gieson stains, but with decrease in smooth muscle cell volume. Bottom row: (J) Elastica-van Gieson
stains of two Turner patients with extensive and (K) focal granular deposition of elastin fibers (arrows) and (L) one healthy control (L).
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aortic stiffness. Our imaging results confirm that the wall of
the aorta is indeed different in patients with TS, even in the
absence of cardiovascular pathology, such as a bicuspid valve,
and this seems especially true for the AA and ascending
aorta. In addition, clear histomorphological changes are
found in the ascending aorta, pointing toward an inherent
abnormal aortic wall.
The observed increased AA-PWV in our study was also
observed by Devos et al9; however, Schäfer et al8 did not find
these results in the younger group of patients with TS. This
may indicate that aortic stiffness occurs later in the disease
process. Besides increased aortic stiffness, patients with TS
also have a higher risk of AA abnormalities, such as elonga-
tion of the AA.17 It might be that anatomical abnormalities in
the arch, including wall abnormalities or anatomical varia-
tions influencing flow patterns, contribute to the occurrence
of dissection in the descending aorta. The majority (54%) of
the patients with TS developed dissection in the ascending
aorta, while only 16.4% developed a dissection in the
descending aorta.18 Further research is required to deter-
mine whether descending aortic dissection can be a result of
long-lasting abnormal flow patterns caused by AA abnor-
malities or increased stiffness as in patients with TS. Conse-
quently, these patients might benefit from more intensive
follow-up and earlier preventive surgery.
In addition, our histomorphological results showed ab-
normalities in the wall of the patients with TS. A hitherto
undescribed and striking pattern, which is not scored in the
current consensus statement,16 was seen in most patients,
with compact smooth muscle cell layers and granular
Fig. 4 Representative electron microscopic images of the aortic media of a women with Turner syndrome (A and B) and a healthy control (C and D).
(A and C)2,800 magnification, (B and D) 7,100 magnification. This figure shows that the elastin lamellae of the women with Turner syndrome are
positioned closer together, more irregular and thinner, and display numerous excrescences on the surface.
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deposition of elastin adjacent to lamellae and in the intra-
lamellar tissue. The described compact smooth muscle cell
layers and a decrease in the intralamellar space without
strong evidence of smooth muscle cell loss indicates a
smooth muscle cell volume loss. This finding is supported
by contractile fiber attenuation demonstrated by a complete
lack of desmin expression, underexpression of caldesmon,
and HHF-35, as well as weak expression of PR. Our results are
in line with amurine study19 that showed decreased smooth
muscle cell content and expression of smoothmuscle actin in
micewith TS. Hinton et al19 also found subtle smoothmuscle
cellmisalignment abnormalities that were not present in our
patients. The phenomena of decreased smooth muscle cell
volume with contractile fiber attenuation and granular
deposition of elastin may be key factors in medial destabili-
zation in TS patients. Because we only included patients who
had undergone surgery for aortic dilatation, these changes
could also be a result of aortic dilatation. However, it is not
consistently present in aortic resection specimens from
other types of connective tissue disease (such as Marfan’s
disease or Loeys–Dietz syndrome [own observation and Jain
et al.20]). Based on our findings, we suggest that both smooth
muscle cell volume and (patterns of) elastin deposition
should be included in future grading schemes to evaluate
aortic tissue, rather than solely focusing on smooth muscle
cell loss and elastin degradation, respectively.
Although histomorphological data confirms that the wall
is different in patientswith TS, the elasticitymeasurement of
the ascending aorta (ascending aortic distensibility) was not
statistically significant different between TS and controls.
This might indicate that elasticity measurements of the
ascending aorta are impeded by nonoptimal diagnostic
power to determine these adverse structural changes within
the aortic vessel wall of individual patients with TS. If that is
the case, hopefully new imaging developments such as
nuclear imaging21 or computational fluid dynamics22 will
help to noninvasively visualize the changes in the aortic wall
or the abnormal blood flow as a result of abnormal aortic
wall behavior. Another reason for our nonsignificantly dif-
ferent ascending aortic distensibility between women with
and without TS might be the limited number of participants.
Since there seemed to be a tendency to a reduced ascending
aortic distensibility in patients with TS, the size of the group
might have prevented us from finding a significant differ-
ence. Others have also investigated whether the presence of
BAV can explain the increased aortic stiffness in patients
Fig. 5 Immunohistochemical stains of patient with Turner syndrome and healthy control. Top row: (A) immunohistochemical caldesmon and (B)
desmin stains of representative aortic explant of controls. Bottom row: (C) immunohistochemical caldesmon and (D) desmin stains of
representative aortic explant of Turner syndrome patient, with appreciable loss of staining in the media for both proteins.
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with TS but the results are contradictory. Two studies8,23
showed reduced ascending aortic distensibility and
increased AA-PWV independently of the presence of BAV,
while Devos et al9 showed that only patients with BAV have a
reduced ascending aortic distensibility. Our results are more
in linewith the first study, sincewe found no effect of BAVon
stiffness. The influence of CoA on aortic stiffness in patients
with TS has been investigated by Wen et al10 who showed
that the aortic distensibility of the descending aortawas only
lower among TS patients with CoA. A history of hypertension
and specific medical treatment and the effect of the treat-
ment could have caused these ambiguous results in different
studies. Our own and former results should be interpreted
with caution and verified in a larger cohort of TS patients,
taking into account the assumed factors which affect the
aortic elasticity.
The aortic stiffness over the entire aortameasuredwith CF-
PWV showed no significant difference between patients with
TS and healthy controls, which is in line with previous litera-
ture.24 Important to acknowledge is that CF-PWV uses
a conventional measurement of the distance on the body
surface. Patients with TS are known to have a fairly abnormal
course of the larger vessels with unrolling and tortuosity.9,25
Because of these aortic abnormalities, measurement of the
aortic length on the outside of the body is likely to fail in
patientswithTS.Weprobablyunderestimatedthelengthof the
aorta, therefore, the value of the CF-PWV will be measured
lower than it actually is. The classic CF-PWV might not be
efficient enough to identify abnormal aortic elasticitywith this
measurement inpatientswithTSduetomethodological issues.
Conclusion
Women with TS show a stiffer AA independently of the
presence of a BAVor CoA. No differenceswere found in aortic
stiffness between patients with monosomy or mosaicism. In
addition, histomorphological changes are found in the
ascending aorta. Our histomorphological investigation pro-
vided new insights into the structure of the aortic wall in
patients with TS. Further research should aim to investigate
whether these structural changes are indeed related to the
markedly different elastic properties of the ascending aorta
in a larger cohort and how we can identify this difference in
elastic properties more accurately with the use of new
imaging developments.
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